BAROSTIM THERAPY in Heart Failure with Reduced Ejection Fraction A Post-Market Registry with the BAROSTIM NEO System
You are invited to participate in a Registry to track the performance of the BAROSTIM NEO Device. You are being invited because you have been implanted with the Device because of your condition called heart failure. In this Registry, you will undergo standard treatment of your heart failure with the BAROSTIM NEO System, which is produced and marketed by CVRx, Inc.
This study is currently enrolling.